专利号:WO-2009073246-A1 优先权日:2007-12-06 标 题 :Method for the synthesis of iridium (iii) complexes with sterically demanding ligands
专利号:US-7417146-B2 优先权日:2004-12-17 标题:Facial tris-cyclometallated group 9 complex synthesis 发明人:HUO SHOUQUAN 权利人:EASTMAN KODAK CO 摘要:A process for forming a facial tris-cyclometallated rhodium or iridium complex isomer from a meridional isomer comprises subjecting the meridional isomer to an isomerization reaction in the presence of an acid, an organic solvent, and silica particles.
专利号:US-8906848-B2 优先权日:2011-04-01 标 题 :Aureobasidin derivatives and methods of synthesis 发明人:WUTS PETER; ELHAMMER AKE P 权利人:WUTS PETER; ELHAMMER AKE P; AUREOGEN BIOSCIENCES INC 摘要:In general, the invention relates to methods of synthesizing AbA derivatives that are useful for treating infection and amenable to further chemical elaboration. These novel methods are scalable for industrial production and employ safer, simpler, and more efficient process conditions. Furthermore, the invention also provides novel compounds and intermediates useful for implementing the methods described herein and/or for the treatment of infection.
专利号:US-2009124805-A1 优先权日:2006-12-08 标题 :Method for synthesis of iriduim (iii) complexes with sterically demanding ligands
专利号:US-8519130-B2 优先权日:2006-12-08 标 题 :Method for synthesis of iriduim (III) complexes with sterically demanding ligands 发明人:ALLEYNE BERT 权利人:ALLEYNE BERT; UNIVERSAL DISPLAY CORP 摘要:Phosphorescent materials and devices with improved device manufacturing, fabrication, stability, efficiency, and/or color.
专利号:US-2008200475-A1 优先权日:2005-03-28 标题:4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors 发明人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH 权利人:PFIZER 摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: (I) wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2a , R x , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.